Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Title
Intervention Indication Therapeutic Area Year Actions
Luspatercept for adult patients with beta-thalassemia who require red blood cell transfusions Luspatercept (ACE-536; Reblozyl) Beta thalassemia Genetic Disorders , Haematology 2018 View  |  Download
Luspatercept for myelodysplastic syndromes (MDS) associated anaemia Luspatercept (ACE-536; Reblozyl) Anaemia due to myelodysplastic syndromes (MDS) Haematological Cancer and Lymphomas , Haematology 2018 View  |  Download
Luspatercept for the treatment of adults with non-transfusion dependent beta-thalassaemia Luspatercept (ACE-536; Reblozyl) Beta thalassemia Genetic Disorders , Haematology 2020 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications